annual FCF:
-$142.25M-$65.36M(-85.00%)Summary
- As of today (May 29, 2025), SMMT annual free cash flow is -$142.25 million, with the most recent change of -$65.36 million (-85.00%) on December 31, 2024.
- During the last 3 years, SMMT annual FCF has fallen by -$69.35 million (-95.14%).
- SMMT annual FCF is now -1044.16% below its all-time high of $15.07 million, reached on January 31, 2017.
Performance
SMMT Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$61.59M-$12.90M(-26.50%)Summary
- As of today (May 29, 2025), SMMT quarterly free cash flow is -$61.59 million, with the most recent change of -$12.90 million (-26.50%) on March 31, 2025.
- Over the past year, SMMT quarterly FCF has dropped by -$31.45 million (-104.36%).
- SMMT quarterly FCF is now -279.08% below its all-time high of $34.39 million, reached on October 31, 2016.
Performance
SMMT quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$173.70M-$31.45M(-22.11%)Summary
- As of today (May 29, 2025), SMMT TTM free cash flow is -$173.70 million, with the most recent change of -$31.45 million (-22.11%) on March 31, 2025.
- Over the past year, SMMT TTM FCF has dropped by -$79.86 million (-85.10%).
- SMMT TTM FCF is now -695.21% below its all-time high of $29.18 million, reached on July 31, 2017.
Performance
SMMT TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
SMMT Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -85.0% | -104.4% | -85.1% |
| 3 y3 years | -95.1% | -218.1% | -142.8% |
| 5 y5 years | -574.2% | -1095.2% | -615.1% |
SMMT Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -237.0% | at low | -1284.2% | at low | -382.1% | at low |
| 5 y | 5-year | -574.2% | at low | -1284.2% | at low | -615.1% | at low |
| alltime | all time | -1044.2% | at low | -279.1% | at low | -695.2% | at low |
SMMT Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$61.59M(+26.5%) | -$173.70M(+22.1%) |
| Dec 2024 | -$142.25M(+85.0%) | -$48.69M(+60.4%) | -$142.25M(+25.9%) |
| Sep 2024 | - | -$30.36M(-8.2%) | -$113.02M(+15.8%) |
| Jun 2024 | - | -$33.06M(+9.7%) | -$97.61M(+4.0%) |
| Mar 2024 | - | -$30.14M(+54.9%) | -$93.84M(+22.1%) |
| Dec 2023 | -$76.89M(+82.2%) | -$19.46M(+30.2%) | -$76.89M(+47.2%) |
| Sep 2023 | - | -$14.95M(-49.0%) | -$52.23M(+14.0%) |
| Jun 2023 | - | -$29.29M(+122.2%) | -$45.81M(+27.2%) |
| Mar 2023 | - | -$13.18M(-353.5%) | -$36.03M(-14.6%) |
| Dec 2022 | -$42.21M(-42.1%) | $5.20M(-160.9%) | -$42.21M(-25.6%) |
| Sep 2022 | - | -$8.54M(-56.3%) | -$56.71M(-20.9%) |
| Jun 2022 | - | -$19.51M(+0.8%) | -$71.73M(+0.3%) |
| Mar 2022 | - | -$19.36M(+108.2%) | -$71.55M(-1.8%) |
| Dec 2021 | -$72.89M(+50.2%) | -$9.30M(-60.5%) | -$72.89M(+1.8%) |
| Sep 2021 | - | -$23.56M(+21.9%) | -$71.61M(+10.6%) |
| Jun 2021 | - | -$19.32M(-6.7%) | -$64.75M(+1.0%) |
| Mar 2021 | - | -$20.71M(+158.2%) | -$64.09M(+32.1%) |
| Dec 2020 | -$48.53M(+130.0%) | - | - |
| Dec 2020 | - | -$8.02M(-51.9%) | -$48.53M(+19.8%) |
| Sep 2020 | - | -$16.69M(-10.6%) | -$40.51M(+24.8%) |
| Jun 2020 | - | -$18.66M(+262.2%) | -$32.47M(+33.7%) |
| Mar 2020 | - | -$5.15M(-40.4%) | -$24.29M(-0.5%) |
| Dec 2019 | -$21.10M(-40.2%) | - | - |
| Oct 2019 | - | -$8.65M(-17.6%) | -$24.40M(+19.3%) |
| Jul 2019 | - | -$10.49M(-683.2%) | -$20.45M(-14.2%) |
| Apr 2019 | - | $1.80M(-125.5%) | -$23.85M(-32.4%) |
| Jan 2019 | -$35.27M | - | - |
| Jan 2019 | - | -$7.06M(+50.2%) | -$35.27M(-5.2%) |
| Oct 2018 | - | -$4.70M(-66.2%) | -$37.19M(-19.7%) |
| Jul 2018 | - | -$13.89M(+44.4%) | -$46.33M(+129.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2018 | - | -$9.62M(+7.1%) | -$20.23M(-4.8%) |
| Jan 2018 | -$21.26M(-241.1%) | - | - |
| Jan 2018 | - | -$8.98M(-35.1%) | -$21.26M(+11.6%) |
| Oct 2017 | - | -$13.85M(-213.4%) | -$19.05M(-165.3%) |
| Jul 2017 | - | $12.21M(-214.7%) | $29.18M(+112.4%) |
| Apr 2017 | - | -$10.64M(+57.1%) | $13.74M(-8.8%) |
| Jan 2017 | $15.07M(-161.3%) | - | - |
| Jan 2017 | - | -$6.78M(-119.7%) | $15.07M(+3.1%) |
| Oct 2016 | - | $34.39M(-1163.1%) | $14.61M(-155.7%) |
| Jul 2016 | - | -$3.23M(-65.3%) | -$26.22M(-6.0%) |
| Apr 2016 | - | -$9.32M(+28.9%) | -$27.89M(+13.6%) |
| Jan 2016 | -$24.56M(+47.6%) | - | - |
| Jan 2016 | - | -$7.23M(+12.2%) | -$24.56M(+12.6%) |
| Oct 2015 | - | -$6.44M(+31.3%) | -$21.81M(+17.6%) |
| Jul 2015 | - | -$4.91M(-18.0%) | -$18.55M(-8.2%) |
| Apr 2015 | - | -$5.99M(+33.6%) | -$20.19M(+21.4%) |
| Jan 2015 | -$16.64M(+70.5%) | - | - |
| Jan 2015 | - | -$4.48M(+41.1%) | -$16.64M(+36.8%) |
| Oct 2014 | - | -$3.17M(-51.6%) | -$12.16M(+35.3%) |
| Jul 2014 | - | -$6.55M(+169.4%) | -$8.99M(+269.4%) |
| Apr 2014 | - | -$2.43M | -$2.43M |
| Jan 2014 | -$9.76M(+89.3%) | - | - |
| Jan 2013 | -$5.15M(+29.1%) | - | - |
| Jan 2012 | -$3.99M(-11.9%) | - | - |
| Jan 2011 | -$4.53M(+62.6%) | - | - |
| Jan 2010 | -$2.79M(-83.0%) | - | - |
| Jan 2009 | -$16.37M(-18.1%) | - | - |
| Jan 2008 | -$19.99M(+114.2%) | - | - |
| Jan 2007 | -$9.33M(+128.8%) | - | - |
| Jan 2006 | -$4.08M(-9520.3%) | - | - |
| Jan 2005 | $43.30K | - | - |
FAQ
- What is Summit Therapeutics annual free cash flow?
- What is the all time high annual FCF for Summit Therapeutics?
- What is Summit Therapeutics annual FCF year-on-year change?
- What is Summit Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Summit Therapeutics?
- What is Summit Therapeutics quarterly FCF year-on-year change?
- What is Summit Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Summit Therapeutics?
- What is Summit Therapeutics TTM FCF year-on-year change?
What is Summit Therapeutics annual free cash flow?
The current annual FCF of SMMT is -$142.25M
What is the all time high annual FCF for Summit Therapeutics?
Summit Therapeutics all-time high annual free cash flow is $15.07M
What is Summit Therapeutics annual FCF year-on-year change?
Over the past year, SMMT annual free cash flow has changed by -$65.36M (-85.00%)
What is Summit Therapeutics quarterly free cash flow?
The current quarterly FCF of SMMT is -$61.59M
What is the all time high quarterly FCF for Summit Therapeutics?
Summit Therapeutics all-time high quarterly free cash flow is $34.39M
What is Summit Therapeutics quarterly FCF year-on-year change?
Over the past year, SMMT quarterly free cash flow has changed by -$31.45M (-104.36%)
What is Summit Therapeutics TTM free cash flow?
The current TTM FCF of SMMT is -$173.70M
What is the all time high TTM FCF for Summit Therapeutics?
Summit Therapeutics all-time high TTM free cash flow is $29.18M
What is Summit Therapeutics TTM FCF year-on-year change?
Over the past year, SMMT TTM free cash flow has changed by -$79.86M (-85.10%)